Medicine


Teva Launches Generic Pristiq Anti-Depression Pill in U.S.

Teva Pharmaceutical Industries announced Wednesday the launch of generic Pristiq 1 (desvenlafaxine) extended-release tablets, 25, 50 and 100 mg, in the U.S. Desvenlafaxine extended-release tablets are a serotonin and norepinephrine…

Read more »

GSK Warns Profits to Be Hit by Generic Drugs Competition

Pharmaceutical company GlaxoSmithKline saw its sales and profits grow in the fourth quarter but warned that tougher competition from generic drugmakers could depress its earnings this year. The London-based company…

Read more »

Resignation of Teva CEO Not Helping Share Prices

The resignation of Teva Pharmaceuticals chairman Erez Vigodman overnight Monday has not helped the company’s stock. In after-hours trading late Monday, the announcement was greeted with further declines in the…

Read more »

U.S. Revises Russia Sanctions for Electronics Exports

The Trump administration on Thursday revised recent U.S. sanctions that prevented American companies from exporting some electronic equipment to Russia. It also modified penalties on Iran, expanding a list of…

Read more »

Teva Loses Copaxone Patent Suit, Share Price Falls

Amid news of a court ruling invalidating several patents on its flagship drug Copaxone, Teva Pharmaceutical Industries’ share price fell 9 percent in New York on Monday, marking a 10-year…

Read more »

FDA Approves Teva Asthma Treatments

Teva Pharmaceutical Industries announced on Monday that the U.S. Food and Drug Administration (FDA) approved two products for adolescent and adult patients with asthma. These products, AirDuo TM RespiClick and…

Read more »

J&J Spends $30B on Switzerland’s Actelion

Johnson & Johnson is buying Swiss pharmaceutical Actelion in a $30 billion deal that will boost its treatments for life-threatening high blood pressure conditions. The deal announced on Thursday comes…

Read more »

Israel Leads the Way in Predictive Analytics

A new digital research institute will utilize patients’ medical information gathered from the national health funds to predict colon cancer and other diseases, Globes reported on Thursday. Biomed investor Morris…

Read more »